These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
63. Olympic reason for generic drug names. Ahlquist RP N Engl J Med; 1972 Nov; 287(18):937. PubMed ID: 5075564 [No Abstract] [Full Text] [Related]
64. Use of generic names--one name only. Wehrli A Int J Clin Pharmacol Ther Toxicol; 1990 Jul; 28(7):315-6. PubMed ID: 2387657 [No Abstract] [Full Text] [Related]
65. NEW generic and brand names recognized by the Council. J Am Med Assoc; 1953 Oct; 153(9):801. PubMed ID: 13096301 [No Abstract] [Full Text] [Related]
66. [Guidelines for the evaluation of publications, testimonies and other data on the therapeutic value of drugs]. Anaesthesist; 1969 Jul; 18(7):232-3. PubMed ID: 5361123 [No Abstract] [Full Text] [Related]
67. Letter: Standardization of drug names. Allan FN JAMA; 1975 Jan; 231(1):24-5. PubMed ID: 1243559 [No Abstract] [Full Text] [Related]
68. Problems with generic theophylline and indiscriminate brand switching. Barreuther A Ann Allergy; 1988 Mar; 60(3):275-6. PubMed ID: 3348509 [No Abstract] [Full Text] [Related]
69. A dose by any other name would not sell as sweet. Stepney R BMJ; 2010 Dec; 341():c6895. PubMed ID: 21159760 [No Abstract] [Full Text] [Related]
71. Generic vs brand. Goldstein DN Wis Med J; 1966 Dec; 65(12):493-4. PubMed ID: 5980483 [No Abstract] [Full Text] [Related]
72. In brief: only the name remains the same. Med Lett Drugs Ther; 2010 Jun; 52(1341):49. PubMed ID: 20585284 [No Abstract] [Full Text] [Related]
73. [Why generic names?]. Westerling R Sven Farm Tidskr; 1965 Sep; 69(26):749-50. PubMed ID: 5868438 [No Abstract] [Full Text] [Related]
74. Comment: converting patients from brand-name clozapine to generic clozapine. Edouard B; Le Foulgocq PL; Guevel C; Materne I Ann Pharmacother; 2001 Oct; 35(10):1295. PubMed ID: 11675868 [No Abstract] [Full Text] [Related]
75. Signs of the times: the need for a stereochemically informative generic name system. Simonyi M; Gal J; Testa B Trends Pharmacol Sci; 1989 Sep; 10(9):349-54. PubMed ID: 2690425 [TBL] [Abstract][Full Text] [Related]
77. Nonequality of brand name thyroxine preparations. Jacobson JM; Ramos-Gabatin A; Young RL; Watkins SC; Brown ML JAMA; 1980 Feb 22-29; 243(8):733. PubMed ID: 7351814 [No Abstract] [Full Text] [Related]